Idiopathic thrombocytopenic purpura (ITP) is a diagnosis of exclusion. It is an autoimmune disorder caused by development of IgG autoantibodies, directed against a number of platelet glycoproteins. A 26 years, primigravida, booked from 30 weeks of gestation, admitted at Sri Ramachandra Medical College and Hospital at 36 weeks of gestation, with gestational hypertension and severe thrombocytopenia with a platelet count of 45,000/mm 3 . She was treated with intravenous steroids during her antenatal period for thrombocytopenia. She delivered a healthy baby girl of weight 2.4 kg by cesarean section and was breastfed. Intra operatively, platelet transfusion was given. Postoperatively, she was on methyl prednisolone following which a good increment in the platelet count was noticed and then discharged. The aim is to clarify when thrombocytopenia in pregnancy is clini cally important, to provide guidance regarding diagnosis, manage ment options and information about potential risks to the mother and the fetus along with the review of relevant literatures.
INTRODUCTION
Idiopathic thrombocytopenic purpura (ITP) is an auto immune disorder, with a platelet count often <80 × 10 9 /l, induced by platelet-specific IgG antibodies. 3 The great concern of ITP during pregnancy is the risk of thrombo cytopenia in the newborn infant.
ITP accounts for 3 to 4%
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Department of Obstetrics and Gynecology, Sri Ramachandra Medical College and Hospital, Chennai, Tamil Nadu, India Corresponding Author: D Sithara, Postgraduate, Department of Obstetrics and Gynecology, Sri Ramachandra Medical College and Hospital, Porur, Chennai600116, Tamil Nadu, India, email: sdjoe389@gmail.com of the cases of thrombocytopenia detected in pregnancy. It has many common causes which includes gestational thrombocytopenia, bacterial and viral infections, pre eclampsia complicated by HELLP syndrome. 1 We present here a case of ITP in pregnancy for its rarity and unique presentation who posed a therapeutic challenge.
CASE REPORT
A 26-year-old primigravida who presented in her 30th week of gestation with severe epistaxis. Her platelet count was ranging between 10,000 and 30,000/mm 3 for which she was treated with intravenous steroids. Steroids were also covered for prematurity. She was diagnosed to have dimorphic anemia and was on iron, folic acid and vitamin B12. Her ANA and anti-dsDNA were negative. At 36th week of gestation, she had intermittent headache and was admitted for safe confinement. Admission platelet count was 45,000/mm 3 and, hence, patient was started on intravenous steroids again, where the platelet counts increased to 1.05 l/mm
3
. At the end of 37th week of gesta tion, she had increased blood pressure and complaints of intermittent headache. She was started on labetalol and nifedipine. Magnetic resonance imaging of brain was done to rule out intracranial bleeding which reported a normal study. Hematology opinion was obtained and ad vised intravenous steroids. Blood bank intimated in prior for the provision of blood and blood products and single donor platelets. On the day of the 38th week of gestation, she had imminent signs of eclampsia and was started on parenteral magnesium sulphate and levetiracetam. Thus, she was admitted at 36 weeks of gestation for gestational hypertension along with ITP, who was followed in the hospital and was decided for termination of pregnancy at 38 weeks of gestation in view of imminent signs of eclampsia. After getting high-risk consent, patient underwent emergency lower segment cesarean section. Intra operatively, she was transfused with 4 units of platelet concentrates and liquor was found to be thick meconium stained. She delivered a baby girl of weight 2.4 kg with a good Apgar score of 8/10 and 9/10. Baby was seen by the neonatologist and was found healthy and breastfeeding was established successfully. Postoperatively, she was started on high dose methyl prednisolone. The platelet counts improved to 1.8 l/mm 3 on the ninth postoperative day and she was discharged home.
DISCUSSION
Idiopathic thrombocytopenic purpura affects 1 to 3 per 1000 pregnancies. 4 During pregnancy, hemodilu tion caused by relative increase in plasma volume coupled with increased platelet turnover leads to the development of thrombocytopenia, accounting for three quarters of cases detected during pregnancy. Idiopathic thrombocytopenic purpura is of three degrees. Mild thrombocytopenia, platelet count <1.5 l/mm. 
